홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
RZLT
#3247
Rezolute, Inc. Common Stock (NV)
3.5
6
USD
-1.39%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
-1.39%
월간 변동
+37.45%
6달 변화
-58.12%
년간 변동율
+34.34%
이전 종가
3.6
1
Open
3.5
5
Bid
Ask
Low
3.5
5
High
3.5
6
양
70
마켓
주식
헬스케어
RZLT
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
8.62 M
38.83 M
36.83 M
55.37 M
90.81 M
—
Valuation ratios
Enterprise value
96.38 M
-10.95 M
56.88 M
168.25 M
310.91 M
1.62 B
Price to earnings ratio
—
-1.39
-1.96
-3.24
-4.55
-17.83
Price to sales ratio
—
13.18
-20.27 K
76.33
—
—
Price to cash flow ratio
—
-1.59
-2.28
-3.87
-4.91
-18.89
Price to book ratio
—
0.42
0.87
1.83
2.09
4.19
EBITDA 비율에 대한 기업 가치
-3.75
0.72
-0.99
-2.39
—
—
Profitability ratios
Return on assets %
-0.49
-0.27
-0.42
-0.52
-0.42
-0.62
Return on equity %
-0.8
-0.27
-0.45
-0.57
-0.46
-0.68
Return on invested capital %
-4 947.38
-12.53 K
-2 102.91
-2 099.83
-4 222.17
—
Gross margin %
57.24
100
100
100
—
—
Operating margin %
-1 279.71
-876.48
1.12 M
-2 423.37
—
—
EBITDA margin %
-1 221.74
-723.94
1.15 M
-2 419.75
—
—
Net margin %
-1 168.36
-860.08
1.04 M
-2 355.78
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
21.34
61.78
20.18
13.39
14.37
52.13
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.07
0.05
-0
0.02
—
—
Solvency ratios
Debt to assets ratio
0.34
0.09
—
—
—
—
Debt to equity ratio
0.55
0.09
—
—
—
—
Long term debt to total assets ratio
0.33
0.09
—
—
—
—
Long term debt to total equity ratio
0.54
0.09
—
—
—
—
Per share metrics
Operating cash flow per share
—
-2.03
-0.87
-1.11
-0.91
-1
EBIT per share
—
-1.9
-1.09
-1.31
—
—
EBITDA per share
—
-1.77
-1.12
-1.37
—
—
Total debt per share
—
0.72
—
—
—
—
Cash per share
—
7.72
1.99
2.47
2.21
6.85
Net current asset value per share
—
7.81
2.05
2.5
2.25
6.98
Tangible book value per share
—
7.67
2.27
2.35
2.13
5.97
Working capital per share
—
7.68
1.95
2.31
2.1
6.42
Book value per share
—
7.67
2.27
2.35
2.13
6.59
뉴스
Rezolute: Sell Rating Despite FDA Feedback From Type B Meeting For Ersodetug (NASDAQ:RZLT)
Rezolute Stock Gains After FDA Meeting on Ersodetug Program Update
XOMA, TD Cowen, Generation Bio 인수 후 ’보유’ 재개
Alger Small Cap Growth Fund Q4 2025 Portfolio Update
제프리스, Rezolute 주식에 ’매수’ 등급 재확인, 목표가 4달러 유지
Jefferies reiterates Buy rating on Rezolute stock, maintains $4 target
레졸루트, 희귀 질환 치료제 3상 시험에서 엇갈린 결과 발표
Rezolute shares mixed results from Phase 3 trial for rare disease therapy
XOMA, Leerink Partners, "매수" 등급 재확인, 목표가 45달러
Leerink Partners reiterates Outperform rating on XOMA stock at $45 target
RZLT Stock Plummets 79% Month to Date: Here's What You Need to Know
레졸루트 CFO, 79,577달러 상당의 주식 매입